Merrimack Pharmaceuticals appoints CFO
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Merrimack Pharmaceuticals Inc. appointed Jean Franchi CFO of the company, effective Aug. 21.
Franchi most recently served as CFO of Dimension Therapeutics Inc.
The company reported in May that Yasir Al-Wakeel, who had served as CFO since August 2015, was leaving the company.
